Cargando…

Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport

BACKGROUND: The hormone leptin exerts its function in the brain to reduce food intake and increase energy expenditure to prevent obesity. However, most obese subjects reflect the resistance to leptin even with elevated serum leptin. Considering that leptin must cross the blood–brain barrier (BBB) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yajuan, Kim, Hyosung, Hamann, Catherine A., Rhea, Elizabeth M., Brunger, Jonathan M., Lippmann, Ethan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494897/
https://www.ncbi.nlm.nih.gov/pubmed/36131285
http://dx.doi.org/10.1186/s12987-022-00375-3
_version_ 1784793891361259520
author Shi, Yajuan
Kim, Hyosung
Hamann, Catherine A.
Rhea, Elizabeth M.
Brunger, Jonathan M.
Lippmann, Ethan S.
author_facet Shi, Yajuan
Kim, Hyosung
Hamann, Catherine A.
Rhea, Elizabeth M.
Brunger, Jonathan M.
Lippmann, Ethan S.
author_sort Shi, Yajuan
collection PubMed
description BACKGROUND: The hormone leptin exerts its function in the brain to reduce food intake and increase energy expenditure to prevent obesity. However, most obese subjects reflect the resistance to leptin even with elevated serum leptin. Considering that leptin must cross the blood–brain barrier (BBB) in several regions to enter the brain parenchyma, altered leptin transport through the BBB might play an important role in leptin resistance and other biological conditions. Here, we report the use of a human induced pluripotent stem cell (iPSC)-derived BBB model to explore mechanisms that influence leptin transport. METHODS: iPSCs were differentiated into brain microvascular endothelial cell (BMEC)-like cells using standard methods. BMEC-like cells were cultured in Transwell filters, treated with ligands from a nuclear receptor agonist library, and assayed for leptin transport using an enzyme-linked immune sorbent assay. RNA sequencing was further used to identify differentially regulated genes and pathways. The role of a select hit in leptin transport was tested with the competitive substrate assay and after gene knockdown using CRISPR techniques. RESULTS: Following a screen of 73 compounds, 17β-estradiol was identified as a compound that could significantly increase leptin transport. RNA sequencing revealed many differentially expressed transmembrane transporters after 17β-estradiol treatment. Of these, cationic amino acid transporter-1 (CAT-1, encoded by SLC7A1) was selected for follow-up analyses due to its high and selective expression in BMECs in vivo. Treatment of BMEC-like cells with CAT-1 substrates, as well as knockdown of CAT-1 expression via CRISPR-mediated epigenome editing, yielded significant increases in leptin transport. CONCLUSIONS: A major female sex hormone, as well as an amino acid transporter, were revealed as regulators of leptin BBB transport in the iPSC-derived BBB model. Outcomes from this work provide insights into regulation of hormone transport across the BBB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00375-3.
format Online
Article
Text
id pubmed-9494897
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94948972022-09-23 Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport Shi, Yajuan Kim, Hyosung Hamann, Catherine A. Rhea, Elizabeth M. Brunger, Jonathan M. Lippmann, Ethan S. Fluids Barriers CNS Research BACKGROUND: The hormone leptin exerts its function in the brain to reduce food intake and increase energy expenditure to prevent obesity. However, most obese subjects reflect the resistance to leptin even with elevated serum leptin. Considering that leptin must cross the blood–brain barrier (BBB) in several regions to enter the brain parenchyma, altered leptin transport through the BBB might play an important role in leptin resistance and other biological conditions. Here, we report the use of a human induced pluripotent stem cell (iPSC)-derived BBB model to explore mechanisms that influence leptin transport. METHODS: iPSCs were differentiated into brain microvascular endothelial cell (BMEC)-like cells using standard methods. BMEC-like cells were cultured in Transwell filters, treated with ligands from a nuclear receptor agonist library, and assayed for leptin transport using an enzyme-linked immune sorbent assay. RNA sequencing was further used to identify differentially regulated genes and pathways. The role of a select hit in leptin transport was tested with the competitive substrate assay and after gene knockdown using CRISPR techniques. RESULTS: Following a screen of 73 compounds, 17β-estradiol was identified as a compound that could significantly increase leptin transport. RNA sequencing revealed many differentially expressed transmembrane transporters after 17β-estradiol treatment. Of these, cationic amino acid transporter-1 (CAT-1, encoded by SLC7A1) was selected for follow-up analyses due to its high and selective expression in BMECs in vivo. Treatment of BMEC-like cells with CAT-1 substrates, as well as knockdown of CAT-1 expression via CRISPR-mediated epigenome editing, yielded significant increases in leptin transport. CONCLUSIONS: A major female sex hormone, as well as an amino acid transporter, were revealed as regulators of leptin BBB transport in the iPSC-derived BBB model. Outcomes from this work provide insights into regulation of hormone transport across the BBB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00375-3. BioMed Central 2022-09-21 /pmc/articles/PMC9494897/ /pubmed/36131285 http://dx.doi.org/10.1186/s12987-022-00375-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shi, Yajuan
Kim, Hyosung
Hamann, Catherine A.
Rhea, Elizabeth M.
Brunger, Jonathan M.
Lippmann, Ethan S.
Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title_full Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title_fullStr Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title_full_unstemmed Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title_short Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
title_sort nuclear receptor ligand screening in an ipsc-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494897/
https://www.ncbi.nlm.nih.gov/pubmed/36131285
http://dx.doi.org/10.1186/s12987-022-00375-3
work_keys_str_mv AT shiyajuan nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport
AT kimhyosung nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport
AT hamanncatherinea nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport
AT rheaelizabethm nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport
AT brungerjonathanm nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport
AT lippmannethans nuclearreceptorligandscreeninginanipscderivedinvitrobloodbrainbarriermodelidentifiesnewcontributorstoleptintransport